Cargando…
Application effect of apatinib in patients with failure of standard treatment for advanced malignant tumours
BACKGROUND: In recent years, targeted therapy has received widespread attention. Among these therapies, anti-angiogenic targeted drugs have become one of the hotspots of research. Apatinib is a novel oral small molecule anti-angiogenic agent that has been clinically tested in a variety of solid tumo...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819520/ https://www.ncbi.nlm.nih.gov/pubmed/31661009 http://dx.doi.org/10.1186/s40360-019-0362-2 |